To determine whether increased cellular iron and increased mitochondrial score have a synergistic effect in MM progression, Kaplan–Meier analyses were performed between patients with different combinations of high- or low-FPN1 with high- or low-mitochondrial-score among the 351 newly diagnosed MM patients enrolled in the TT2 trial. The gene discussed is SLC40A1; the disease is Miyoshi myopathy.